Matthew Davidson
Vermögen: 338 612 $ am 30.09.2026
Vermögen: 338 612 $ am 30.09.2026
Dr. Matthew Davidson is a President, Chief Executive Officer & Director at Adial Pharmaceuticals, Inc. and a President, Chief Executive & Financial Officer at Azora Therapeutics, Inc. He is on the Board of Directors at Adial Pharmaceuticals, Inc. Dr. Davidson was previously employed as a Chief Scientific Officer & Director by Verrica Pharmaceuticals, Inc. He received his undergraduate degree from the University of California, Berkeley and a doctorate degree from Stanford University School of Medicine.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 17.08.2026 | 84’442 ( 3.22% ) | 338 612 $ | 30.09.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
Azora Therapeutics, Inc.
Azora Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops treatments for inflammatory diseases | Vorstandsvorsitzender | 01.03.2019 |
| Unternehmen | Position | Ende |
|---|---|---|
| ADIAL PHARMACEUTICALS, INC. | Vorstandsvorsitzender | - |
| VERRICA PHARMACEUTICALS INC. | Gründer | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 5 |
|---|---|
Adial Pharmaceuticals, Inc.
Adial Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes medications to treat addiction and related disorders | Health Technology |
University of California, Berkeley
University of California, Berkeley Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Stanford University School of Medicine
Stanford University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Verrica Pharmaceuticals, Inc.
Verrica Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Azora Therapeutics, Inc.
Azora Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops treatments for inflammatory diseases | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen